Skip to main content
Clinical Trials/CTRI/2021/12/038997
CTRI/2021/12/038997
Completed
Phase 3

Comparison of nalbuphine versus buprenorphine as an adjuvant to epidural ropivacaine in lower abdomen and lower limb surgeries

AASWI0 sites70 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
AASWI
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
AASWI

Eligibility Criteria

Inclusion Criteria

  • 1\)ASA 1 \& 2
  • 2\)Age 18 to 60 years of both sex
  • 3\) Patients undergoing elective lower abdomen and lower limb surgeries

Exclusion Criteria

  • 1\)Patients not willing
  • 2\) allergic to specific drugs
  • 3\)pregnant women
  • 4\) contraindications for epidural anesthesia
  • 5\)intraoperative surgical complications like massive blood loss \& haemodynamic instability
  • 6\)Patients with sensory \& motor deficit

Outcomes

Primary Outcomes

Not specified

Similar Trials